Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Inactivation of α1-proteinase inhibitor by Candida albicans aspartic proteases favors the epithelial and endothelial cell colonization in the presence of neutrophil extracellular traps.

Gogol M, Ostrowska D, Klaga K, Bochenska O, Wolak N, Aoki W, Ueda M, Kozik A, Rapala-Kozik M.

Acta Biochim Pol. 2016;63(1):167-175. doi: 10.18388/abp.2015_1163. Epub 2015 Dec 7.

2.

Inactivation of the antifungal and immunomodulatory properties of human cathelicidin LL-37 by aspartic proteases produced by the pathogenic yeast Candida albicans.

Rapala-Kozik M, Bochenska O, Zawrotniak M, Wolak N, Trebacz G, Gogol M, Ostrowska D, Aoki W, Ueda M, Kozik A.

Infect Immun. 2015 Jun;83(6):2518-30. doi: 10.1128/IAI.00023-15. Epub 2015 Apr 6.

3.

Aspartic Proteases and Major Cell Wall Components in Candida albicans Trigger the Release of Neutrophil Extracellular Traps.

Zawrotniak M, Bochenska O, Karkowska-Kuleta J, Seweryn-Ozog K, Aoki W, Ueda M, Kozik A, Rapala-Kozik M.

Front Cell Infect Microbiol. 2017 Sep 21;7:414. doi: 10.3389/fcimb.2017.00414. eCollection 2017.

4.

Kinin release from human kininogen by 10 aspartic proteases produced by pathogenic yeast Candida albicans.

Kozik A, Gogol M, Bochenska O, Karkowska-Kuleta J, Wolak N, Kamysz W, Aoki W, Ueda M, Faussner A, Rapala-Kozik M.

BMC Microbiol. 2015 Mar 4;15:60. doi: 10.1186/s12866-015-0394-8.

5.

Aspartic protease inhibitors: effective drugs against the human fungal pathogen Candida albicans.

Santos AL, Braga-Silva LA.

Mini Rev Med Chem. 2013 Jan;13(1):155-62. Review.

PMID:
23256485
6.

The action of ten secreted aspartic proteases of pathogenic yeast Candida albicans on major human salivary antimicrobial peptide, histatin 5.

Bochenska O, Rapala-Kozik M, Wolak N, Aoki W, Ueda M, Kozik A.

Acta Biochim Pol. 2016;63(3):403-10. doi: 10.18388/abp.2016_1318. Epub 2016 Jul 8.

7.

Inactivation of human kininogen-derived antimicrobial peptides by secreted aspartic proteases produced by the pathogenic yeast Candida albicans.

Bochenska O, Rapala-Kozik M, Wolak N, Kamysz W, Grzywacz D, Aoki W, Ueda M, Kozik A.

Biol Chem. 2015 Dec;396(12):1369-75. doi: 10.1515/hsz-2015-0167.

PMID:
26351912
8.

Candida albicans secreted aspartic proteases 4-6 induce apoptosis of epithelial cells by a novel Trojan horse mechanism.

Wu H, Downs D, Ghosh K, Ghosh AK, Staib P, Monod M, Tang J.

FASEB J. 2013 Jun;27(6):2132-44. doi: 10.1096/fj.12-214353. Epub 2013 Feb 19.

PMID:
23430844
9.
10.

Differential Proteinase Patterns among Candida albicans Strains Isolated from Root Canal and Lingual Dorsum: Possible Roles in Periapical Disease.

Miranda TT, Vianna CR, Rodrigues L, Rosa CA, Corrêa A Jr.

J Endod. 2015 Jun;41(6):841-5. doi: 10.1016/j.joen.2015.01.012. Epub 2015 Mar 11.

PMID:
25771140
11.

Secretory Aspartyl Proteinases Cause Vaginitis and Can Mediate Vaginitis Caused by Candida albicans in Mice.

Pericolini E, Gabrielli E, Amacker M, Kasper L, Roselletti E, Luciano E, Sabbatini S, Kaeser M, Moser C, Hube B, Vecchiarelli A, Cassone A.

MBio. 2015 Jun 2;6(3):e00724. doi: 10.1128/mBio.00724-15.

12.

A novel immune evasion strategy of candida albicans: proteolytic cleavage of a salivary antimicrobial peptide.

Meiller TF, Hube B, Schild L, Shirtliff ME, Scheper MA, Winkler R, Ton A, Jabra-Rizk MA.

PLoS One. 2009;4(4):e5039. doi: 10.1371/journal.pone.0005039. Epub 2009 Apr 7.

13.

Effect of nonsteroidal antiinflammatory drugs on the neutrophil promoted inactivation of alpha-1-proteinase inhibitor.

Dallegri F, Ottonello L, Dapino P, Sacchetti C.

J Rheumatol. 1992 Mar;19(3):419-23.

PMID:
1578457
15.

Comparative cleavage sites within the reactive-site loop of native and oxidized alpha1-proteinase inhibitor by selected bacterial proteinases.

Rapala-Kozik M, Potempa J, Nelson D, Kozik A, Travis J.

Biol Chem. 1999 Oct;380(10):1211-6.

PMID:
10595584
16.

Secreted aspartic protease cleavage of Candida albicans Msb2 activates Cek1 MAPK signaling affecting biofilm formation and oropharyngeal candidiasis.

Puri S, Kumar R, Chadha S, Tati S, Conti HR, Hube B, Cullen PJ, Edgerton M.

PLoS One. 2012;7(11):e46020. doi: 10.1371/journal.pone.0046020. Epub 2012 Nov 6. Erratum in: PLoS One. 2013;8(8). doi:10.1371/annotation/13ef5e14-c192-4bb2-af91-886024500b4b.

17.

Secreted aspartic proteases of Candida albicans activate the NLRP3 inflammasome.

Pietrella D, Pandey N, Gabrielli E, Pericolini E, Perito S, Kasper L, Bistoni F, Cassone A, Hube B, Vecchiarelli A.

Eur J Immunol. 2013 Mar;43(3):679-92. doi: 10.1002/eji.201242691. Epub 2013 Jan 31.

18.

Comprehensive characterization of secreted aspartic proteases encoded by a virulence gene family in Candida albicans.

Aoki W, Kitahara N, Miura N, Morisaka H, Yamamoto Y, Kuroda K, Ueda M.

J Biochem. 2011 Oct;150(4):431-8. doi: 10.1093/jb/mvr073. Epub 2011 Jun 5.

PMID:
21646240
19.

The glycosylphosphatidylinositol-anchored protease Sap9 modulates the interaction of Candida albicans with human neutrophils.

Hornbach A, Heyken A, Schild L, Hube B, Löffler J, Kurzai O.

Infect Immun. 2009 Dec;77(12):5216-24. doi: 10.1128/IAI.00723-09. Epub 2009 Oct 5.

20.

Candida albicans possesses Sap7 as a pepstatin A-insensitive secreted aspartic protease.

Aoki W, Kitahara N, Miura N, Morisaka H, Yamamoto Y, Kuroda K, Ueda M.

PLoS One. 2012;7(2):e32513. doi: 10.1371/journal.pone.0032513. Epub 2012 Feb 27.

Supplemental Content

Support Center